Respiratory Drug Discovery
Charles River has a long history of experience with all aspects of respiratory therapy research—from discovery of novel compounds and efficacy evaluation to safety evaluation by all clinical routes, including inhalation. Since 2005, our scientists have been named as co-inventors on nearly 70 patents for novel compounds for respiratory indications and have delivered 25 preclinical development candidates in this area.
Our scientists can help you manage the unique challenges associated with your respiratory discovery program.
Ask a respiratory expert »